Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today ...

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately.

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately.

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to ...

The WEB 17 occlusion device. [Image courtesy of MicroVention] Terumo subsidiary MicroVention announced recent one-year study results supporting the use of its WEB 17 occlusion device. The company ...

MicroVention is Also Celebrating the Five-Year Anniversary of its WEB™ Aneurysm Embolization System with more than 10,000 Units Sold in the United States COLORADO SPRINGS, Colo. & ALISO VIEJO, Calif., ...

US-based neuroendovascular device company MicroVention has announced a court settlement against three former members of staff accused of misappropriating trade secrets about the company’s embolic ...

(MENAFN- AETOSWire) (BUSINESS WIRE )--MicroVention, a fully owned subsidiary of Terumo Corporation, announced today that the United States District Court for the Central District of California has ...